TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J.C. Penney adopts 'poison pill' strategy

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

By The Associated Press
Friday, Aug. 23, 2013, 12:01 a.m.
 

Struggling retailer J.C. Penney is adopting a plan to prevent a takeover attempt just two days after reporting its sixth straight quarter of big losses and steep revenue declines.

It's the second time in recent years that the company has put into place a so-called “poison pill” plan. In October 2010, J.C. Penney enacted the defense when activist investor William Ackman of Pershing Square and Vornado Square Management, chaired by Steve Roth, snapped up large stakes. The company eventually put both men on its board; Ackman resigned last week, capping a public feud with other directors. Roth is still on the board.

J.C. Penney said there is no current attempt to take over the company.

Under the plan, if an individual or entity acquires 10 percent or more of the company's outstanding stock, existing shareholders would be allowed to buy more shares at a very low price.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Federal agency checking whether Highmark has enough doctors in Medicare plan
  2. Lower gasoline prices fail to spur consumer spending
  3. Retailers that won’t open on Thanksgiving hope move pays off
  4. Google applies tech to medical device
  5. Oil prices continue descent, dragging market indexes lower
  6. Small businesses’ dilemma: Keep costly health care coverage or lose talented workers
  7. Westinghouse to construct colossal nuke plant in Turkey
  8. Household debt on the rise after 5-year decline
  9. Thanksgiving deals called the best
  10. Axed contracts push doctors from network, UPMC says
  11. Housing prices nudge upward as more homes on market
Subscribe today! Click here for our subscription offers.